Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization studyPauline M. Ellerbroek, Leman Yel, András Nagy et al.|Immunotherapy|2024Cited by 5
Non-interventional post-marketing safety study on the long-term safety of HyQvia (global)Lina Morales Laguado, Leman Yel, Barbara McCoy et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2018Cited by 0